SCHEMBL22030672

SCHEMBL22030672

O=C(O)CNC(=O)c1ccccccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.68
▸ MAPT P10636 2/20 0.68
▸ KDM4E B2RXH2 1/20 0.68
▸ HIF1A Q16665 1/20 0.68
▸ SLC22A6 Q4U2R8 1/20 0.68
▸ SLC22A8 Q8TCC7 1/20 0.68
▸ CA1 P00915 2/20 0.59
▸ CA2 P00918 1/20 0.59
▸ PTPRC P08575 2/20 0.57
▸ CTSL P07711 1/20 0.57
▸ PTPN13 Q12923 1/20 0.57
▸ ATM Q13315 1/20 0.56
▸ NPC1 O15118 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ GPR139 Q6DWJ6 1/20 0.54
▸ HDAC3 O15379 1/20 0.54
▸ CA12 O43570 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hippuric Acid SCHEMBL7486 1.00 GAA (0.68) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL428479 1.00 GAA (0.68) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL587978 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL21569381 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL11656206 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL7796688 0.98 KDM4E (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL1179259 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL7398337 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL3448563 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6
Hippuric Acid SCHEMBL1458080 0.98 MAPT (0.66) GAAMAPTKDM4EHIF1ASLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200165272-A1 BORATE COMPOUND, AND SYNTHESIS METHOD THEREFOR AND USES THEREOF CHENGDU ORIGIN BIOTECHNOLOGY LIMITED COMPANY (CN) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165272-A1 BORATE COMPOUND, AND SYNTHESIS METHOD THEREFOR AND USES THEREOF PSMB11, PSMC5, SEM1 GAA 231/4885MAPT 1242/4885KDM4E 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback